88 related articles for article (PubMed ID: 16887657)
1. Characterization of beta-lactam-resistant Bacteroides fragilis isolates by use of PCR fingerprinting.
Fang H; Hedberg M; Edlund C; Jarstrand C; Fodor E; Nord CE
Anaerobe; 1999 Feb; 5(1):11-8. PubMed ID: 16887657
[TBL] [Abstract][Full Text] [Related]
2. Identification and strain differentiation of 'Bacteroides fragilis group' species and Prevotella bivia by PCR fingerprinting.
Claros M; Schönian G; Gräser Y; Montag T; Rodloff AC; Citron DM; Goldstein EJ
Anaerobe; 1995 Aug; 1(4):209-17. PubMed ID: 16887529
[TBL] [Abstract][Full Text] [Related]
3. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
Schaumann R; Petzold S; Fille M; Rodloff AC
Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets.
Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E
Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091
[TBL] [Abstract][Full Text] [Related]
5. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE;
Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857
[TBL] [Abstract][Full Text] [Related]
6. Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles.
Claros MC; Citron DM; Hunt Gerardo S; Goldstein EJ; Schönian G; Montag T; Hampel B; Rodloff AC
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S66-72. PubMed ID: 8953109
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis.
Bogaerts P; Engelhardt A; Berhin C; Bylund L; Ho P; Yusof A; Glupczynski Y
Clin Microbiol Infect; 2008 Oct; 14(10):973-7. PubMed ID: 18828856
[TBL] [Abstract][Full Text] [Related]
8. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
[TBL] [Abstract][Full Text] [Related]
9. Screening of isolates from faeces for carbapenem-resistant Bacteroides strains; existence of strains with novel types of resistance mechanisms.
Sóki J; Edwards R; Urbán E; Fodor E; Beer Z; Nagy E
Int J Antimicrob Agents; 2004 Nov; 24(5):450-4. PubMed ID: 15519476
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibility to antimicrobial drugs of enterotoxin producing strains of Bacteroides fragilis isolated from different countries].
Obuch-Woszczatyński P; Rokosz A; Sawicka-Grzelak A; Pituch H; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2002; 54(3):253-8. PubMed ID: 12632660
[TBL] [Abstract][Full Text] [Related]
11. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
[TBL] [Abstract][Full Text] [Related]
12. Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States.
Claros MC; Hunt Gerardo S; Citron DM; Goldstein EJ; Schönian G; Rodloff AC
Clin Infect Dis; 1997 Sep; 25 Suppl 2():S295-8. PubMed ID: 9310712
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota.
Ulger Toprak N; Celik C; Cakici O; Soyletir G
Anaerobe; 2004 Oct; 10(5):255-9. PubMed ID: 16701525
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey.
Behra-Miellet J; Calvet L; Mory F; Muller C; Chomarat M; Bézian MC; Bland S; Juvenin ME; Fosse T; Goldstein F; Jaulhac B; Dubreuil L
Anaerobe; 2003 Jun; 9(3):105-11. PubMed ID: 16887696
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
Shen JL; Zhu DM; Wang MG
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
[TBL] [Abstract][Full Text] [Related]
16. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
17. Identification of Bacteroides fragilisby a modified immuno polymerase chain reaction (mIPCR), using a specific monoclonal antibody.
Zhang G; Pan Q; Weintraub A
Anaerobe; 1998 Aug; 4(4):189-96. PubMed ID: 16887641
[TBL] [Abstract][Full Text] [Related]
18. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.
Chen YG; Zhang Y; Yu YS; Qu TT; Wei ZQ; Shen P; Li LJ
Int J Antimicrob Agents; 2008 Oct; 32(4):302-7. PubMed ID: 18556176
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates.
Claros MC; Claros ZC; Hecht DW; Citron DM; Goldstein EJ; Silva J; Tang-Feldman Y; Rodloff AC
Anaerobe; 2006 Feb; 12(1):17-22. PubMed ID: 16701608
[TBL] [Abstract][Full Text] [Related]
20. [Molecular cloning of the imipenem resistant gene in bacteroides fragilis].
Zhou Z; Fan X; Feng P; Lü X; Lin J; Zhang H; Lu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):184-7. PubMed ID: 10683931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
